发明申请
US20120190739A1 EP2 AND EP4 AGONISTS AS AGENTS FOR THE TREATMENT OF INFLUENZA A VIRAL INFECTION
审中-公开
EP2和EP4作为治疗流感病毒感染的代理人
- 专利标题： EP2 AND EP4 AGONISTS AS AGENTS FOR THE TREATMENT OF INFLUENZA A VIRAL INFECTION
- 专利标题（中）： EP2和EP4作为治疗流感病毒感染的代理人
-
申请号： US13073889申请日： 2011-03-28
-
公开(公告)号： US20120190739A1公开(公告)日： 2012-07-26
- 发明人: Daryl Faulds , William J. Guilford , Wolfgang Seifert
- 申请人： Daryl Faulds , William J. Guilford , Wolfgang Seifert
- 申请人地址： US CA San Francisco
- 专利权人： GEMMUS PHARMA INC.
- 当前专利权人： GEMMUS PHARMA INC.
- 当前专利权人地址： US CA San Francisco
- 主分类号： A61K31/5585
- IPC分类号： A61K31/5585 ; A61K31/5575 ; A61P31/16 ; A61K31/5578
摘要：
The present invention is directed to the use of EP2 and/or EP4 agonists as therapeutics for the treatment of diseases associated with influenza A viruses, such as for example H5N1 and mutations thereof.
公开/授权文献
信息查询
